Erythrocyte Membrane Cholesterol Is Closely Associated with the Onset of the PCI-related Coronary Slow Flow or No Reflow Phenomenon in Patients with Non-ST Elevated Acute Coronary Syndrome
Aim To investigate if erythrocyte membrane cholesterol (EMC) precipitated the onset of the percutaneous coronary intervention (PCI)-related coronary slow or no reflow phenomenon, and to determine if EMC was a new predictor for this PCI-related coronary slow or no reflow in patients with non-ST elevated acute coronary syndrome (ACS).